PHARMAGILLY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAGILLY
Largest movements
- Tangible fixed assets -€47,841
down €47,841 (-10.1%), from €472,946 to €425,105
of which Land and buildings: -€46,339
- Cash -€41,544
down €41,544 (-89.1%), from €46,650 to €5,106
mainly Debts after one year (-€46,421) and Net result for the year (-€26,702)
- Stocks and contracts +€14,557
up €14,557 (+9.6%), from €151,448 to €166,005
- Debts after one year -€46,421
down €46,421 (-11.7%), from €397,508 to €351,087
- Profit (loss) carried forward -€26,702
down €26,702 (-18.6%), from €143,457 to €116,755
- Trade debts -€24,382
down €24,382 (-44.3%), from €55,027 to €30,644
- Other debts +€19,076
up €19,076 (+35.9%), from €53,193 to €72,268
- Tax, wage and social debts +€12,245
up €12,245 (+77.7%), from €15,752 to €27,997
of which Remuneration and social security: +€9,144
- Staff costs +€58,443
up €58,443 (+203.2%), from €28,759 to €87,203
- Gross operating margin -€14,971
down €14,971 (-11.1%), from €135,195 to €120,224
- Taxes -€13,690
down €13,690 (-100.0%), from €13,690 to €0
- Other operating charges +€3,291
up €3,291 (+154.1%), from €2,136 to €5,427
- Depreciation -€1,651
down €1,651 (-3.3%), from €50,706 to €49,055
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €793,505 | €717,024 | -€76,481 | -9.6% |
| Fixed assets | 21/28 | €473,142 | €425,301 | -€47,841 | -10.1% |
| Tangible fixed assets | 22/27 | €472,946 | €425,105 | -€47,841 | -10.1% |
| Land and buildings | 22 | €467,752 | €421,413 | -€46,339 | -9.9% |
| Furniture and vehicles | 24 | €5,194 | €3,692 | -€1,502 | -28.9% |
| Financial fixed assets | 28 | €196 | €196 | = | 0.0% |
| Current assets | 29/58 | €320,364 | €291,724 | -€28,640 | -8.9% |
| Stocks and contracts in progress | 3 | €151,448 | €166,005 | +€14,557 | +9.6% |
| Stocks | 30/36 | €151,448 | €166,005 | +€14,557 | +9.6% |
| Amounts receivable within one year | 40/41 | €122,070 | €120,405 | -€1,665 | -1.4% |
| Trade receivables | 40 | €84,829 | €60,936 | -€23,893 | -28.2% |
| Other amounts receivable | 41 | €37,241 | €59,469 | +€22,228 | +59.7% |
| Cash at bank and in hand | 54/58 | €46,650 | €5,106 | -€41,544 | -89.1% |
| Deferred charges and accrued income | 490/1 | €197 | €208 | +€12 | +5.9% |
| Total equity and liabilities | 10/49 | €793,505 | €717,024 | -€76,481 | -9.6% |
| Equity | 10/15 | €215,307 | €188,605 | -€26,702 | -12.4% |
| Contributions | 10/11 | €65,000 | €65,000 | = | 0.0% |
| Capital | 10 | €65,000 | €65,000 | = | 0.0% |
| Issued capital | 100 | €65,000 | €65,000 | = | 0.0% |
| Revaluation surpluses | 12 | €86 | €86 | = | 0.0% |
| Reserves | 13 | €6,763 | €6,763 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,763 | €6,763 | = | 0.0% |
| Legal reserve | 130 | €6,763 | €6,763 | = | 0.0% |
| Profit (loss) carried forward | 14 | €143,457 | €116,755 | -€26,702 | -18.6% |
| Amounts payable | 17/49 | €578,198 | €528,420 | -€49,779 | -8.6% |
| Amounts payable after more than one year | 17 | €397,508 | €351,087 | -€46,421 | -11.7% |
| Financial debts | 170/4 | €397,508 | €351,087 | -€46,421 | -11.7% |
| Amounts payable within one year | 42/48 | €169,680 | €177,331 | +€7,650 | +4.5% |
| Current portion of amounts payable after more than one year | 42 | €45,709 | €46,421 | +€712 | +1.6% |
| Trade debts | 44 | €55,027 | €30,644 | -€24,382 | -44.3% |
| Suppliers | 440/4 | €55,027 | €30,644 | -€24,382 | -44.3% |
| Taxes, remuneration and social security | 45 | €15,752 | €27,997 | +€12,245 | +77.7% |
| Taxes | 450/3 | €12,953 | €16,054 | +€3,100 | +23.9% |
| Remuneration and social security | 454/9 | €2,799 | €11,943 | +€9,144 | +326.7% |
| Other amounts payable | 47/48 | €53,193 | €72,268 | +€19,076 | +35.9% |
| Accrued charges and deferred income | 492/3 | €11,010 | €2 | -€11,008 | -100.0% |
| Remuneration, social security and pensions | 62 | €28,759 | €87,203 | +€58,443 | +203.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €50,706 | €49,055 | -€1,651 | -3.3% |
| Other operating charges | 640/8 | €2,136 | €5,427 | +€3,291 | +154.1% |
| Gross operating margin | 9900 | €135,195 | €120,224 | -€14,971 | -11.1% |
| Operating profit (loss) | 9901 | €53,594 | -€21,461 | -€75,055 | |
| Financial income | 75/76B | €1,936 | €2,047 | +€111 | +5.7% |
| Recurring financial income | 75 | €1,936 | €2,047 | +€111 | +5.7% |
| Financial charges | 65/66B | €8,230 | €7,289 | -€941 | -11.4% |
| Recurring financial charges | 65 | €8,230 | €7,289 | -€941 | -11.4% |
| Profit (loss) for the period before taxes | 9903 | €47,300 | -€26,702 | -€74,002 | |
| Income taxes | 67/77 | €13,690 | €0 | -€13,690 | -100.0% |
| Profit (loss) for the period | 9904 | €33,610 | -€26,702 | -€60,313 | |
| Profit (loss) for the period to be appropriated | 9905 | €33,610 | -€26,702 | -€60,313 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.